Abstract:N-6 methyladenine (m(6)A) modification of the FzD5 mRNA, an important post-transcriptional regulation in eukaryotes, is closely related to the occurrence and development of breast cancer. Here, we developed an ultra-sensitive biosensor based on MazF combining with cascaded strand displacement amplification (CSDA) and CRISPR/Cas12a to detect m(6)A FzD5 mRNA. MazF toxin protein is a vital component of the bacterial mazEF toxin-antitoxin system that is sensitive to m(6)A RNA. Take advantage of it, the biosensor achieved antibody-independent and gene-specific detection for m(6)A RNA. Moreover, compared with traditional amplification methods, the more efficient C-SDA and the CRISPR/Cas12a system with trans-cleavage activity gave the fluorescent biosensor an excellent sensitivity with the detection limit of 0.64 fM. In addition, MazF, as a new antibacterial target, was detected by the biosensor based on C-SDA and CRISPR/Cas12a with the detection limit of 1.127 x 10(-4) U mL(-1). More importantly, the biosensor has good performance in complex samples. Therefore, the biosensor is a potential tool in detecting m(6)A FzD5 mRNA and MazF activity. (C) 2021 Elsevier B.V. All rights reserved. N6 methyladenine (m(6)A) modification of the FzD5 mRNA, an important post-transcriptional regulation in eukaryotes, is closely related to the occurrence and development of breast cancer. Here, we developed an ultra-sensitive biosensor based on MazF combining with cascaded strand displacement amplification (CSDA) and CRISPR/Cas12a to detect m(6)A FzD5 mRNA. MazF toxin protein is a vital component of the bacterial mazEF toxin-antitoxin system that is sensitive to m6A RNA. Take advantage of it, the biosensor achieved antibody-independent and gene-specific detection for m(6)A RNA. Moreover, compared with traditional amplification methods, the more efficient C-SDA and the CRISPR/Cas12a system with trans-cleavage activity gave the fluorescent biosensor an excellent sensitivity with the detection limit of 0.64 fM. In addition, MazF, as a new antibacterial target, was detected by the biosensor based on C-SDA and CRISPR/Cas12a with the detection limit of 1.127 x 10(-4) U mL(-1). More importantly, the biosensor has good performance in complex samples. Therefore, the biosensor is a potential tool in detecting m(6)A FzD5 mRNA and MazF activity. (C) 2021 Elsevier B.V. All rights reserved.

The Fluorescent Biosensor for Detecting N6 Methyladenine FzD5 Mrna and MazF Activity.

An RNA Methylation-Sensitive AIEgen-Aptamer Reporting System for Quantitatively Evaluating M6a Methylase and Demethylase Activities

MazF-rolling circle amplification combined MALDI-TOF MS for site-specific detection of N6-methyladenosine RNA

Characterization of eukaryotic DNA N 6 -methyladenine by a highly sensitive restriction enzyme-assisted sequencing

Methylation-Powered Assembly of a Single Quantum Dot-Based FRET Nanosensor for Antibody-Free and Enzyme-Free Monitoring of Locus-Specific N 6 -Methyladenosine in Clinical Tissues

Targeted Manipulation of Cellular RNA m6A Methylation at theSingle-Base Level br

RNA methylation-driven assembly of fluorescence-encoded nanostructures for sensitive detection of m 6 A modification writer METTL3/14 complex in human breast tissues

DNAzyme based three-way junction assay for antibody-free detection of locus-specific N6-methyladenosine modifications

DNAzyme mediated catalytic hairpin self-assembly strategy enables the sensitive and facile investigation of N-methyladenine

Assembly of Dandelion-Like Nanoprobe for Sensitive Detection of N6-Methyladenosine Demethylase by Single-Molecule Counting

Controllable assembly of dendritic DNA nanostructures for ultrasensitive detection of METTL3-METTL14 m6A methyltransferase activity in cancer cells and human breast tissues

Highly Sensitive and Selective Demethylase FTO Detection Using a DNAzyme-mediated CRISPR/Cas12a Signal Cascade Amplification Electrochemiluminescence Biosensor with C-CN/PCNV Heterojunction As Emitter

Construction of a Label-Free Fluorescent Biosensor for Homogeneous Detection of M6a Eraser FTO in Breast Cancer Tissues.

Construction of a Quantum-Dot-Based FRET Nanosensor through Direct Encoding of Streptavidin-Binding RNA Aptamers for N6-Methyladenosine Demethylase Detection

Engineering M6a Demethylation-Activated DNAzyme for Visually and Sensitively Sensing Fat Mass and Obesity-Associated Protein

Demethylase FTO activity analysis based on methyl sensitive enzyme MazF and hybridization chain reaction

Double blocking gap-filling-ligation coupled with cascade isothermal amplification for ultrasensitive quantification of N6-methyladenosine

A Label‐free Deoxyribozyme Sensor for m6A Demethylase Activity Detection

Development of a N 6 -methyladenosine-directed single quantum dot-based biosensor for sensitive detection of METTL3/14 complex activity in breast cancer tissues

Identification and quantification of N 6 -methyladenosine by chemical derivatization coupled with 19 F NMR spectroscopy

Mass-Spectrometry-Based Assay at Single-Base Resolution for Simultaneously Detecting M6a and M6am in RNA